Coverage and Cost-of-Care Links: Addressing Financial Toxicity Among Patients With Hematologic Cancer and Their Caregivers
- PMID: 36888937
- PMCID: PMC10414719
- DOI: 10.1200/OP.22.00665
Coverage and Cost-of-Care Links: Addressing Financial Toxicity Among Patients With Hematologic Cancer and Their Caregivers
Abstract
Purpose: This study examined the feasibility, acceptability, and preliminary effectiveness of an oncology financial navigation (OFN) intervention, Coverage and Cost-of-Care Links (CC Links), among patients with hematologic cancer and their caregivers who are at increased risk of experiencing financial toxicity (FT).
Methods: All patients who presented to the Division of Hematology and Bone and Marrow Transplant (BMT) at an National Cancer Institute-designated cancer center between April 2021 and January 2022 were screened for FT during inpatient and outpatient visits. Patients who screened positive for FT and met the inclusion criteria were recruited to participate in CC Links that provided financial navigation and assistance via a financial navigator. Caregivers of patients undergoing BMTs were also recruited to participate. Primary outcomes were defined as improvements in FT, distress, and physical and mental quality of life.
Results: Fifty-four patients and 32 caregivers completed the intervention and pre-/postintervention surveys. CC Links resulted in statistically significant decreases in the Comprehensive Score for FT for both patients (|t| = 2.42, P = .019) and caregivers (|t| = 2.43, P = .021) and total FT (|t| = 2.13, P = .041) and material conditions scores (|t| = 2.25, P = .031) for caregivers only. Only 27% of eligible patients participated in the study, whereas 100% of eligible caregivers participated. The majority of participants rated the intervention highly for acceptability (89%) and appropriateness (88%). An average of $2,500 (USD) in financial benefits was secured per participant via CC Links.
Conclusion: CC Links was effective in decreasing FT among patients with hematologic cancer and their caregivers while demonstrating high acceptability and appropriateness ratings.
Conflict of interest statement
The following represents disclosure information provided by authors of this manuscript. All relationships are considered compensated unless otherwise noted. Relationships are self-held unless noted. I = Immediate Family Member, Inst = My Institution. Relationships may not relate to the subject matter of this manuscript. For more information about ASCO's conflict of interest policy, please refer to
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (
Figures
Similar articles
-
A dyadic analysis of financial toxicity and health-related quality of life among bone marrow transplant patients and their caregivers.Psychooncology. 2024 Feb;33(2):e6303. doi: 10.1002/pon.6303. Psychooncology. 2024. PMID: 38342820 Free PMC article.
-
Lessening the Impact of Financial Toxicity (LIFT): a protocol for a multi-site, single-arm trial examining the effect of financial navigation on financial toxicity in adult patients with cancer in rural and non-rural settings.Trials. 2022 Oct 3;23(1):839. doi: 10.1186/s13063-022-06745-4. Trials. 2022. PMID: 36192802 Free PMC article.
-
Financial Toxicity Intervention Improves Outcomes in Patients With Hematologic Malignancy.JCO Oncol Pract. 2022 Sep;18(9):e1494-e1504. doi: 10.1200/OP.22.00056. Epub 2022 Jun 16. JCO Oncol Pract. 2022. PMID: 35709421
-
Financial Toxicity in Patients with Hematologic Malignancies: a Review and Need for Interventions.Curr Hematol Malig Rep. 2023 Oct;18(5):158-166. doi: 10.1007/s11899-023-00707-6. Epub 2023 Jul 25. Curr Hematol Malig Rep. 2023. PMID: 37490228 Review.
-
Financial toxicity in hematological malignancies: a systematic review.Blood Cancer J. 2022 Apr 22;12(4):74. doi: 10.1038/s41408-022-00671-z. Blood Cancer J. 2022. PMID: 35459862 Free PMC article.
Cited by
-
Racial and Rural Disparities in Financial Toxicity and Healthcare Transitions Among Adolescent and Young Adult Cancer Survivors in Kentucky: A Cross-Sectional Study.Cancer Control. 2025 Jan-Dec;32:10732748251339251. doi: 10.1177/10732748251339251. Epub 2025 May 6. Cancer Control. 2025. PMID: 40327040 Free PMC article.
-
Analysis of Online Crowdfunding Among Patients Pursuing Metabolic and Bariatric Surgery in the United States.Obes Surg. 2025 Jan;35(1):170-180. doi: 10.1007/s11695-024-07605-7. Epub 2024 Dec 4. Obes Surg. 2025. PMID: 39633092
-
Financial Toxicity, Time Toxicity, and Quality of Life in Multiple Myeloma.Clin Lymphoma Myeloma Leuk. 2024 Jul;24(7):446-454.e3. doi: 10.1016/j.clml.2024.02.013. Epub 2024 Feb 23. Clin Lymphoma Myeloma Leuk. 2024. PMID: 38521640 Free PMC article.
-
A Scoping Review of Interventions to Address Financial Toxicity in Pediatric and Adult Patients and Survivors of Cancer.Cancer Med. 2025 Apr;14(8):e70879. doi: 10.1002/cam4.70879. Cancer Med. 2025. PMID: 40247815 Free PMC article.
-
Financial toxicity of hemophilia care in Southeast Asian countries.Lancet Reg Health Southeast Asia. 2025 Jun 13;38:100610. doi: 10.1016/j.lansea.2025.100610. eCollection 2025 Jul. Lancet Reg Health Southeast Asia. 2025. PMID: 40584693 Free PMC article. Review.
References
-
- Siegel RL, Miller KD, Jemal A: Cancer statistics. CA: A Cancer J Clin 68:7-30, 2018 - PubMed
-
- Meropol NJ, Schrag D, Smith TJ, et al. : American society of clinical oncology guidance statement: The cost of cancer care. J Clin Oncol 27:3868-3874, 2009 - PubMed
-
- Huntington SF, Weiss BM, Vogl DT, et al. : Financial toxicity in insured patients with multiple myeloma: A cross-sectional pilot study. Lancet Haematol 2:e408-e416, 2015 - PubMed
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous